Try our beta test site

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

This study has been completed.
Sponsor:
Collaborators:
National Cancer Institute (NCI)
AEterna Zentaris
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01240629
First received: June 30, 2010
Last updated: February 3, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2, 2017
  Primary Completion Date: February 2, 2017 (Final data collection date for primary outcome measure)